Thursday, August 28th, 2025
Stock Profile: STAA
STAA Logo

STAAR Surgical Company (STAA)

Market: NASD | Currency: USD

Address: 25651 Atlantic Ocean Drive

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Show more




📈 STAAR Surgical Company Historical Chart






📊 Statistics





💰 Dividend History


No dividend history available.



📅 Earnings & EPS History for STAAR Surgical Company


DateReported EPS
2025-10-29 (estimated upcoming)-
2025-08-06-0.34
2025-05-07-1
2025-02-11-0.69
2024-10-300.22
2024-08-070.39
2024-05-070.11
2024-02-260.13
2023-11-010.3
2023-08-020.4
2023-05-030.18
2023-02-210.14
2022-11-020.37
2022-08-100.42
2022-05-040.29
2022-02-230.19
2021-11-030.21
2021-08-040.27
2021-05-050.2
2021-02-240.14
2020-11-040.15
2020-08-050.03
2020-05-060.04
2020-02-260.12
2019-10-300.12




📰 Related News & Research


No related articles found for "staar surgical".